HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Del Labs

This article was originally published in The Rose Sheet

Executive Summary

Del Labs: Shareholder Larry Zucker sues Del's board of directors on Aug. 9, charging the board with breaching its fiduciary duties when it agreed to settle a government suit alleging that Del Chairman, President and CEO Dan Wassong sexually harassed former employees ("The Rose Sheet" Aug. 7, p. 10). Del agreed to pay $1.2 mil. under the EEOC settlement and said it will retain Wassong in his current position...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001920

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel